A molecular signature for the metabolic syndrome by urine metabolomics

[1]  B. Falkner,et al.  The Metabolic Syndrome—What Is It and How Should It Be Managed? , 2006, Journal of clinical hypertension.

[2]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[3]  Gregory Kaltsas,et al.  Metabolic syndrome: definitions and controversies , 2011, BMC medicine.

[4]  H. Neuhauser.  The metabolic syndrome , 2005, The Lancet.

[5]  B. Comte,et al.  Metabolomic and Lipidomic Signatures of Metabolic Syndrome and its Physiological Components in Adults: A Systematic Review , 2020, Scientific Reports.

[6]  D. Cohen,et al.  Publisher's Note , 2017, Neuroscience & Biobehavioral Reviews.

[7]  Elena Caceaune.  THE RELATIONSHIP BETWEEN NONALCOHOLIC FATTY LIVER DISEASE AND THE METABOLIC SYNDROME , 2012 .

[8]  Nurshad Ali,et al.  Association of microalbuminuria with metabolic syndrome: a cross-sectional study in Bangladesh , 2020, BMC Endocrine Disorders.

[9]  B. Balkau,et al.  The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation , 2015, Obesity.

[10]  K. Kawecka-Jaszcz,et al.  Association of free testosterone and sex hormone binding globulin with metabolic syndrome and subclinical atherosclerosis but not blood pressure in hypertensive perimenopausal women , 2016, Archives of medical science : AMS.

[11]  L. O’Driscoll,et al.  Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[12]  R. Gil-Redondo,et al.  1H-NMR-based urine metabolomics reveals signs of enhanced carbon and nitrogen recycling in prostate cancer. , 2020, Journal of proteome research.

[13]  Blandine Comte,et al.  Systems Metabolomics for Prediction of Metabolic Syndrome. , 2017, Journal of proteome research.

[14]  X. Escoté,et al.  Detection of Early Disease Risk Factors Associated with Metabolic Syndrome: A New Era with the NMR Metabolomics Assessment , 2020, Nutrients.

[15]  C. Bouchard,et al.  Contribution of age and declining androgen levels to features of the metabolic syndrome in men. , 2005, Metabolism: clinical and experimental.

[16]  Shelly C. Lu,et al.  SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum , 2020, iScience.

[17]  C. Hellerbrand,et al.  Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. , 2014, Best practice & research. Clinical gastroenterology.

[18]  Shao-hua Chen,et al.  Relationship between nonalcoholic fatty liver disease and metabolic syndrome , 2011, Journal of digestive diseases.

[19]  Arshag D Mooradian,et al.  Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. , 2002, Diabetes care.

[20]  I. Jialal,et al.  Amino acid levels in nascent metabolic syndrome: A contributor to the pro-inflammatory burden. , 2018, Journal of diabetes and its complications.

[21]  Siddharth Singh,et al.  Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta‐analysis , 2015, Hepatology.

[22]  A. Burt,et al.  Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. , 2015, Journal of hepatology.

[23]  Zerihun T. Dame,et al.  The Human Urine Metabolome , 2013, PloS one.

[24]  Tero Aittokallio,et al.  Early metabolic markers identify potential targets for the prevention of type 2 diabetes , 2017, Diabetologia.

[25]  U. Kujala,et al.  Serum metabolic profiles in overweight and obese women with and without metabolic syndrome , 2014, Diabetology & Metabolic Syndrome.

[26]  A. Mykletun,et al.  Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study , 2007, BMC public health.

[27]  G. Radaelli,et al.  Circulating Salicylic Acid and Metabolic Profile after 1-Year Nutritional–Behavioral Intervention in Children with Obesity , 2019, Nutrients.

[28]  H. Soula,et al.  p-Cresyl sulfate promotes insulin resistance associated with CKD. , 2013, Journal of the American Society of Nephrology : JASN.

[29]  C. Day.  Metabolic syndrome, or What you will: definitions and epidemiology , 2007, Diabetes & vascular disease research.

[30]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[31]  G. Muscogiuri,et al.  Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome , 2018, Nutrients.

[32]  E. Randell,et al.  Unfavorable Associations Between Serum Trimethylamine N-Oxide and L-Carnitine Levels With Components of Metabolic Syndrome in the Newfoundland Population , 2019, Front. Endocrinol..

[33]  G. Molderings,et al.  Why Imidazoline Receptor Modulator in the Treatment of Hypertension? , 1995, Annals of the New York Academy of Sciences.

[34]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[35]  Ming-Huei Chen,et al.  Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes , 2016, PloS one.

[36]  J. Tuomilehto,et al.  The metabolic syndrome – What is it and how should it be managed? , 2019, European journal of preventive cardiology.

[37]  Arshag D Mooradian,et al.  Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. , 2003, Diabetes care.

[38]  V. Athyros,et al.  Hypertension in Metabolic Syndrome: novel insights. , 2020, Current hypertension reviews.

[39]  D. Panagiotakos,et al.  Amino acid profile and metabolic syndrome in a male Mediterranean population: A cross-sectional study. , 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[40]  Ralph A. DeFronzo,et al.  Diabetes Complications, Comorbidities and Related Disorders , 2018, Endocrinology.

[41]  S. Weisnagel,et al.  Increased body fat mass explains the positive association between circulating estradiol and insulin resistance in postmenopausal women. , 2018, American journal of physiology. Endocrinology and metabolism.

[42]  Ivano Bertini,et al.  Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks , 2011, Journal of biomolecular NMR.

[43]  B. Adams-Huet,et al.  Exploratory lipidomics in patients with nascent Metabolic Syndrome. , 2018, Journal of diabetes and its complications.

[44]  G. Alberti.  Introduction to the metabolic syndrome , 2005 .

[45]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[46]  F. Cappuccio,et al.  Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population. , 2008, Metabolism: clinical and experimental.

[47]  E. Seely,et al.  The association between phthalates and metabolic syndrome: the National Health and Nutrition Examination Survey 2001–2010 , 2016, Environmental Health.

[48]  S. Grundy.  Metabolic Syndrome Pandemic , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[49]  A. Hudson,et al.  Imidazoline Receptor System: The Past, the Present, and the Future , 2020, Pharmacological Reviews.

[50]  I. Jialal,et al.  Exploratory metabolomics of metabolic syndrome: A status report , 2019, World journal of diabetes.

[51]  I. Jialal,et al.  Exploratory metabolomics of nascent metabolic syndrome. , 2019, Journal of diabetes and its complications.